Business Context and Reporting Period
This Form 6-K filing by Evogene Ltd. covers the month of December 2025, with a report date of December 30, 2025. The filing serves to disclose specific changes in the company's management structure.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly focused on corporate governance updates and does not contain financial performance data.
Material Changes
The primary material change reported is an appointment to the executive team:
- Ms. Olga Nissan has been appointed as Vice President of Business Development.
- The appointment is effective as of January 1, 2026.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, management commentary on operations, or specific risk factors. The document incorporates a press release (Exhibit 99.1) by reference into existing registration statements, excluding specific statements from the incoming Vice President and the CEO.
Key Facts for Investor Verification
- Verify the effective date of Ms. Olga Nissan's appointment (January 1, 2026).
- Review the full text of the press release (Exhibit 99.1) for details on Ms. Nissan's background and strategic role.
- Confirm that no financial results were included in this specific filing.